التفاصيل البيبلوغرافية
| العنوان: |
Safety of SGLT2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Receptor Agonists in US Veterans with and without Chronic Kidney Disease: A Population-Based Study |
| المؤلفون: |
Narasaki, Yoko, Kovesdy, Csaba P., You, Amy S., Sumida, Keiichi, Mallisetty, Yamini, Surbhi, Satya, Thomas, Fridtjof, Amin, Alpesh N., Streja, Elani, Kalantar-Zadeh, Kamyar, Rhee, Connie M. |
| المصدر: |
The Lancet Regional Health - Americas; 20240101, Issue: Preprints |
| مستخلص: |
We examined the real-world comparative safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs. other newer anti-glycemic medications (dipeptidyl peptidase-4 inhibitors [DPP4i], glucagon-like peptide-1 receptor agonists [GLP1a]) in patients with and without chronic kidney disease (CKD). |
| قاعدة البيانات: |
Supplemental Index |
Full Text Finder